Kessler L, Richter K
Center for Devices and Radiological Health, U.S. Food & Drug Administration, Rockville, MD 20850, USA.
Am J Manag Care. 1998 Sep 25;4 Spec No:SP129-35.
We reviewed the Food and Drug Administration's regulatory process for medical devices and described the issues that arise in assessing device safety and effectiveness during the postmarket period. The Center for Devices and Radiological Health (CDRH), an organization within the Food and Drug Administration, has the legal authority and responsibility for ensuring that medical devices marketed in the United States are both reasonably safe and effective for their intended use. This is an enormous challenge given the diversity of medical devices and the large number of different types of devices on the market. Many scientific and regulatory activities are necessary to ensure device safety and effectiveness, including technology assessment, albeit in a manner quite different from that of conventional technology assessment. The basic approach taken at the CDRH to ensure device safety and effectiveness is to develop an understanding of the way in which a medical device works and how it will perform in clinical situations.
我们回顾了美国食品药品监督管理局(Food and Drug Administration)对医疗器械的监管流程,并描述了在上市后阶段评估器械安全性和有效性时出现的问题。器械与放射健康中心(Center for Devices and Radiological Health,CDRH)是美国食品药品监督管理局下属的一个机构,拥有法律授权和责任,以确保在美国市场上销售的医疗器械对于其预期用途而言既合理安全又有效。鉴于医疗器械的多样性以及市场上大量不同类型的器械,这是一项巨大的挑战。为确保器械的安全性和有效性,需要开展许多科学和监管活动,包括技术评估,尽管其方式与传统技术评估有很大不同。CDRH确保器械安全性和有效性所采用的基本方法是深入了解医疗器械的工作方式及其在临床环境中的表现。